136 related articles for article (PubMed ID: 1349259)
1. The effect of azelastine on the early allergic response.
Shin MH; Baroody F; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Clin Exp Allergy; 1992 Feb; 22(2):289-95. PubMed ID: 1349259
[TBL] [Abstract][Full Text] [Related]
2. The effect of cetirizine on early allergic response.
Naclerio RM; Proud D; Kagey-Sobotka A; Freidhoff L; Norman PS; Lichtenstein LM
Laryngoscope; 1989 Jun; 99(6 Pt 1):596-9. PubMed ID: 2566879
[TBL] [Abstract][Full Text] [Related]
3. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
[TBL] [Abstract][Full Text] [Related]
4. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen.
Majchel AM; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Clin Exp Allergy; 1990 Nov; 20(6):701-5. PubMed ID: 1707333
[TBL] [Abstract][Full Text] [Related]
5. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
[TBL] [Abstract][Full Text] [Related]
6. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
[TBL] [Abstract][Full Text] [Related]
7. The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen.
Thomas KE; Ollier S; Ferguson H; Davies RJ
Clin Exp Allergy; 1992 Jun; 22(6):642-7. PubMed ID: 1393763
[TBL] [Abstract][Full Text] [Related]
8. The effects of H1 antihistamines on the early allergic response.
Baroody F; Proud D; Kagey-Sobotka A; Freidhoff L; Norman PS; Lichtenstein LM; Naclerio RM
Ann Allergy; 1989 Dec; 63(6 Pt 2):551-5. PubMed ID: 2574550
[TBL] [Abstract][Full Text] [Related]
9. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
[TBL] [Abstract][Full Text] [Related]
10. The effect of antihistamines on the immediate allergic response: a comparative review.
Naclerio RM
Otolaryngol Head Neck Surg; 1993 Jun; 108(6):723-30. PubMed ID: 8100058
[TBL] [Abstract][Full Text] [Related]
11. Effects of intranasal azelastine on the response to nasal allergen challenge.
Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
[TBL] [Abstract][Full Text] [Related]
12. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the anti-allergic activity of azelastine on the immediate and late-phase reactions to allergens and histamine using telethermography.
De Weck AL; Derer T; Bähre M
Clin Exp Allergy; 2000 Feb; 30(2):283-7. PubMed ID: 10651782
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
15. Mediator release after allergic and physical nasal challenges.
Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
17. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
Chung JH; deTineo ML; Naclerio RM; Sorrentino JV; Winslow CM; Baroody FM
Ann Allergy Asthma Immunol; 1997 Mar; 78(3):307-12. PubMed ID: 9087158
[TBL] [Abstract][Full Text] [Related]
18. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
Knapp HR
N Engl J Med; 1990 Dec; 323(25):1745-8. PubMed ID: 1701029
[TBL] [Abstract][Full Text] [Related]
19. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
Herman D; Garay R; Le Gal M
Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
